Authors:
CAIRNCROSS JG
UEKI K
ZLATESCU MC
LISLE DK
FINKELSTEIN DM
HAMMOND RR
SILVER JS
STARK PC
MACDONALD DR
INO Y
RAMSAY DA
LOUIS DN
Citation: Jg. Cairncross et al., SPECIFIC GENETIC PREDICTORS OF CHEMOTHERAPEUTIC RESPONSE AND SURVIVALIN PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMAS, Journal of the National Cancer Institute, 90(19), 1998, pp. 1473-1479
Authors:
ROSENBERG JE
LISLE DK
BURWICK JA
UEKI K
VONDEIMLING A
MOHRENWEISER HW
LOUIS DN
Citation: Je. Rosenberg et al., REFINED DELETION MAPPING OF THE CHROMOSOME 19Q GLIOMA TUMOR-SUPPRESSOR GENE TO THE D19S412-STD INTERVAL, Oncogene, 13(11), 1996, pp. 2483-2485
Authors:
LOUIS DN
ROSENBERG JE
UEKI K
LISLE DK
BURWICK JA
Citation: Dn. Louis et al., THE CHROMOSOME 19Q GLIOMA TUMOR-SUPPRESSOR GENE - FURTHER MAPPING ANDCLONING EFFORTS, Journal of neuropathology and experimental neurology, 55(5), 1996, pp. 4-4
Citation: Jt. Joseph et al., NF2 GENE ANALYSIS IN HEMANGIOPERICYTOMAS AND MENINGIOMAS, Journal of neuropathology and experimental neurology, 54(3), 1995, pp. 467-467
Authors:
JOSEPH JT
LISLE DK
JACOBY LB
PAULUS W
BARONE R
COHEN ML
ROGGENDORF WH
BRUNER JM
GUSELLA JF
LOUIS DN
Citation: Jt. Joseph et al., NF2 GENE ANALYSIS DISTINGUISHES HEMANGIOPERICYTOMA FROM MENINGIOMA, The American journal of pathology, 147(5), 1995, pp. 1450-1455